Ceesay Abraham — SEC Form 4 filings
SEC reporting owner CIK 1722140. 20 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-06-10 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 39 legs across 13 filings — 230,624 shares, $8,055,458 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 39,435 shares @ $26.30 ($1,037,101) in Rapport Therapeutics, Inc., filed 2025-09-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer, Director | 15 | — | 38 legs · 228,270 sh · $7,991,453 | 3 |
| Pacira BioSciences, Inc. (PCRX) | Director | 3 | — | 1 leg · 2,354 sh · $64,005 | 4 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | 2 | — | — | 3 |
Form 4 filings — Ceesay Abraham
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 7,141 @ $45.55 · Sale (S): 1,069 @ $46.01 | EDGAR |
| 2026-08-26 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 18,921 @ $49.57 | EDGAR |
| 2026-08-12 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 14,171 @ $45.97 · Sale (S): 8,370 @ $46.75 · Sale (S): 3,664 @ $46.90 · Sale (S): 19,500 @ $48.04 · Sale (S): 5,794 @ $48.62 | EDGAR |
| 2026-07-29 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 2,203 @ $42.11 · Sale (S): 7 @ $42.73 | EDGAR |
| 2026-07-15 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 5,481 @ $39.72 · Sale (S): 2,729 @ $40.57 | EDGAR |
| 2026-07-01 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 7,344 @ $39.77 · Sale (S): 876 @ $40.34 | EDGAR |
| 2026-05-11 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 1,438 @ $177.62 | EDGAR |
| 2026-02-19 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 3,552 @ $29.05 · Sale (S): 2,281 @ $29.80 · Sale (S): 2,983 @ $29.04 · Sale (S): 2,100 @ $29.80 | EDGAR |
| 2026-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 428,000 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 5,833 @ $26.12 · Sale (S): 5,083 @ $26.11 | EDGAR |
| 2025-12-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 2,441 @ $28.84 · Sale (S): 2,792 @ $30.04 · Sale (S): 600 @ $31.04 · Sale (S): 2,147 @ $28.84 · Sale (S): 2,421 @ $30.04 · Sale (S): 515 @ $31.04 | EDGAR |
| 2025-11-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 2,777 @ $24.92 · Sale (S): 3,056 @ $25.43 · Sale (S): 2,242 @ $24.91 · Sale (S): 2,841 @ $25.44 | EDGAR |
| 2025-10-16 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 4,647 @ $25.72 · Sale (S): 1,186 @ $26.14 · Sale (S): 4,328 @ $25.75 · Sale (S): 755 @ $26.17 | EDGAR |
| 2025-09-19 | 4 | Rapport Therapeutics, Inc. (RAPP) | Sale (S): 39,435 @ $26.30 · Sale (S): 1,400 @ $26.87 · Sale (S): 34,885 @ $26.30 · Sale (S): 700 @ $27.04 | EDGAR |
| 2025-09-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 2,354 @ $27.19 | EDGAR |
| 2025-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 946 @ $135.04 · Grant/award (A): 2,082 (derivative) @ $135.04 | EDGAR |
| 2025-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 428,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 530,647 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1722140 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →